| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| axitinib pembrolizumab | 0.95 | 0.3 | 1719 | 57 | 22 |
| axitinib | 0.7 | 0.7 | 2660 | 50 | 8 |
| pembrolizumab | 1.32 | 0.2 | 9182 | 51 | 13 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| axitinib pembrolizumab | 1.1 | 0.1 | 8871 | 81 |
| axitinib pembrolizumab side effects | 0.68 | 0.3 | 9643 | 4 |
| axitinib pembrolizumab cost | 1.26 | 0.2 | 2453 | 40 |
| axitinib pembrolizumab dose | 1.09 | 0.8 | 6578 | 64 |
| axitinib pembrolizumab survival | 0.59 | 0.6 | 2161 | 92 |
| axitinib pembrolizumab efficacy | 1.55 | 0.3 | 4758 | 42 |
| axitinib pembrolizumab combination | 1.57 | 0.5 | 6021 | 53 |
| axitinib pembrolizumab immunotherapy | 1.7 | 0.8 | 414 | 39 |
| axitinib pembrolizumab rcc | 1.75 | 0.3 | 8779 | 68 |
| axitinib pembrolizumab mechanism of action | 0.04 | 0.9 | 9912 | 53 |
| axitinib pembrolizumab renal cell carcinoma | 1.83 | 0.6 | 6491 | 61 |
| axitinib pembrolizumab trial | 1.65 | 0.7 | 9470 | 93 |
| axitinib pembrolizumab sarcoma | 0.12 | 0.2 | 9205 | 69 |
| axitinib pembrolizumab side effects treatment | 1.76 | 0.3 | 8088 | 93 |
| axitinib pembrolizumab effetti collaterali | 1.33 | 1 | 7654 | 22 |
| pembrolizumab and axitinib | 0.4 | 0.7 | 851 | 61 |
